Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HealthEquity, Inc. - Common Stock (NQ: HQY )

97.15 +1.47 (+1.54%)
Streaming Delayed Price Updated: 11:12 AM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about HealthEquity, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending. 
Via Benzinga
Yext, Oracle, Huize Holding And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Insights into HealthEquity Q3 Earnings
Via Benzinga
Earnings Breakdown: HealthEquity Q3
Via Benzinga
HealthEquity Earnings Analysis: Q3 Recap
Via Benzinga
Earnings Summary: HealthEquity Q3
Via Benzinga
HealthEquity Q3 Earnings Assessment
Via Benzinga
HealthEquity Earnings Report: Q3 Overview
Via Benzinga
NASDAQ:HQY—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
HEALTHEQUITY INC (NASDAQ:HQY), a strong growth stock, setting up for a breakout. 
Via Chartmill
Earnings Scheduled For December 9, 2024
Via Benzinga
Insights into HealthEquity's Upcoming Earnings
Via Benzinga
Expert Ratings For HealthEquity
Via Benzinga
Netflix To Rally More Than 7%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Why NASDAQ:HQY Is a Standout High-Growth Stock in a Consolidation Phase.
Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Standout High-Growth Stock in a Consolidation Phase. 
Via Chartmill
In-Depth Examination Of 8 Analyst Recommendations For HealthEquity
Via Benzinga
Why NASDAQ:HQY Is a Promising High-Growth Stock in the Midst of Consolidation.
Why HEALTHEQUITY INC (NASDAQ:HQY) Is a Promising High-Growth Stock in the Midst of Consolidation. 
Via Chartmill
Here's How Much You Would Have Made Owning HealthEquity Stock In The Last 10 Years
Via Benzinga
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Exposures Political
Russell 2000 Surge Post-Election: How to Play the Small-Cap Pop
As the presidential election results come in, market reactions leave investors wondering where the next best step may come from. 
Via MarketBeat
Topics Bonds ETFs Economy
Exposures Debt Markets Economy Political
How Will HealthEquity, Other Medtechs Do Under Harris Or Trump Administration?
It has a near-perfect 96 Composite Rating and a C+ Accumulation/Distribution Rating, showing that big funds are buying its shares. 
Via Investor's Business Daily
Topics Government
Exposures Political
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Navigating 8 Analyst Ratings For HealthEquity
Via Benzinga
NASDAQ:HQY qualifies as a high growth stock and is consolidating.
Is HEALTHEQUITY INC (NASDAQ:HQY) on the Verge of a Major Breakout as a Strong Growth Stock? 
Via Chartmill
Buckle Up And Use Volitility To Your Advantage
The Advance/Decline trend on the NYSE weakened; the Nasdaq A/D line is outright scary. 
Via Talk Markets
How Is The Market Feeling About HealthEquity?
Via Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Dow Hits Record High, S&P 500 Gains For 4th Consecutive Month: Fear Index In 'Greed' Zone
Via Benzinga
Topics Stocks
Exposures US Equities
Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Critical Insights From HealthEquity Analyst Ratings: What You Need To Know
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.